Aprikose Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Jaipur, Rajasthan, India, established in 2016.
2016 Jaipur, Rajasthan, India Active
Last Updated:
Access Report
About Aprikose Pharmaceuticals Private Limited

Aprikose Pharmaceuticals Private Limited, a active private limited company, was established on 25 April 2016 in Jaipur, Rajasthan, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230RJ2016PTC054738. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Muskan Kumawat (Additional Director), Harish Dublad (Director). Past directors included Vikram Jeet. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at P .No. B -2 -A, Surjan Vihar, Nandpuri, Jaipur, Rajasthan, 302006.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230RJ2016PTC054738

  • Registration Number

    054738

  • Incorporation Date

    25 April 2016

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Jaipur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 9 Months
  • Last Filing with ROC 31 Mar 2019
  • Revenue Growth **** 31.73%
  • Profit Growth **** 71.88%
  • Ebitda **** 75.48%
  • Net Worth -21.99%
  • Total Assets **** 26.09%
Company report

Aprikose Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aprikose Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aprikose Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Muskan Kumawat Additional Director 11 May 2024 Current
Harish Dublad Director 25 Apr 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 13 May 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aprikose Pharmaceuticals.

Aprikose Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 31.73% increase. The company also saw a substantial improvement in profitability, with a 71.88% increase in profit. The company's net worth observed a substantial decline by a decrease of 21.99%.

Aprikose Pharmaceuticals revenue growth over time
Aprikose Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 31.73%
*******
*******
*******
*******
Revenue from Operations
*******
 31.73%
*******
*******
*******
*******
Total Assets
*******
 26.09%
*******
*******
*******
*******
Profit or Loss
*******
 71.88%
*******
*******
*******
*******
Net Worth
*******
 -21.99%
*******
*******
*******
*******
EBITDA
*******
 75.48%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aprikose Pharmaceuticals?

In 2019, Aprikose Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aprikose Pharmaceuticals?

Unlock and access historical data on people associated with Aprikose Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aprikose Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aprikose Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aprikose Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Muskan Kumawat was appointed as a Additional Director was appointed as a Additional Director on 11 May 2024 & has been associated with this company since 1 year 9 months . was completed.

  • Annual General Meeting

    The activity Aprikose Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Aprikose Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Jaipur. was completed.

  • Director Appointment

    Harish Dublad was appointed as a Director was appointed as a Director on 25 Apr 2016 & has been associated with this company since 9 years 9 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Aprikose Pharmaceuticals Private Limited was registered on 25 Apr 2016 with Roc Jaipur & aged 9 years 9 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aprikose Pharmaceuticals Private Limited?

The CIN of Aprikose Pharmaceuticals Private Limited is U24230RJ2016PTC054738.

Where is Aprikose Pharmaceuticals Private Limited headquartered?

Aprikose Pharmaceuticals Private Limited is headquartered at P .No. B -2 -A, Surjan Vihar, Nandpuri, Jaipur, Rajasthan, 302006.

When was Aprikose Pharmaceuticals Private Limited incorporated?

Aprikose Pharmaceuticals Private Limited was incorporated on 25 April 2016.

Who are the current directors of Aprikose Pharmaceuticals Private Limited?

The current directors of Aprikose Pharmaceuticals Private Limited are

What is the primary industry of Aprikose Pharmaceuticals Private Limited?

The primary industry of Aprikose Pharmaceuticals Private Limited is Trade.

Is Aprikose Pharmaceuticals Private Limited a listed company?

Aprikose Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Aprikose Pharmaceuticals Private Limited?

The authorized capital of Aprikose Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Aprikose Pharmaceuticals Private Limited?

The compliance status of Aprikose Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available